Traynor Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.55M | Buy |
|
|||||
|
2025
Q2 | $1.16M | Sell |
|
|||||
|
2025
Q1 | $1.37M | Buy |
|
|||||
|
2024
Q4 | $1.12M | Buy |
|
|||||
|
2024
Q3 | $1.11M | Buy |
|
|||||
|
2024
Q2 | $821K | Buy |
|
|||||
|
2024
Q1 | $785K | Buy |
|
|||||
|
2023
Q4 | $638K | Buy |
|
|||||
|
2023
Q3 | $565K | Sell |
|
|||||
|
2023
Q2 | $562K | Buy |
|
|||||
|
2023
Q1 | $661K | Buy |
|
|||||
|
2022
Q4 | $581K | Buy |
|
|||||
|
2022
Q3 | $459K | Buy |
|
|||||
|
2022
Q2 | $485K | Sell |
|
|||||
|
2022
Q1 | $633K | Buy |
|
|||||
|
2021
Q4 | $528K | Sell |
|
|||||
|
2021
Q3 | $459K | Buy |
|
|||||
|
2021
Q2 | $441K | Buy |
|
|||||
|
2021
Q1 | $396K | Buy |
|
|||||
|
2020
Q4 | $300K | Sell |
|
|||||
|
2020
Q3 | $394K | Buy |
|
|||||
|
2020
Q2 | $454K | Buy |
|
|||||
|
2020
Q1 | $318K | Sell |
|
|||||
|
2019
Q4 | $504K | Buy |
|
|||||
|
2019
Q3 | $416K | Buy |
|
|||||
|
2019
Q2 | $370K | Sell |
|
|||||
|
2019
Q1 | $505K | Sell |
|
|||||
|
2018
Q4 | $611K | Buy |
|
|||||
|
2018
Q3 | $543K | Buy |
|
|||||
|
2018
Q2 | $480K | Sell |
|
|||||
|
2018
Q1 | $596K | Buy |
|
|||||
|
2017
Q4 | $497K | Buy |
|
|||||
|
2017
Q3 | $451K | Buy |
|
|||||
|
2017
Q2 | $355K | Sell |
|
|||||
|
2017
Q1 | $499K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $205K | Buy |
|